Schaper Benz & Wise Investment Counsel’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,000
Closed -$305K 160
2025
Q4
$305K Buy
+3,000
New +$241K 0.02% 140
2023
Q3
Sell
-2,200
Closed -$207K 135
2023
Q2
$207K Buy
+2,200
New +$172K 0.02% 133
2022
Q2
Sell
-3,485
Closed -$244K 148
2022
Q1
$244K Buy
3,485
+300
+9% +$21.9K 0.02% 137
2021
Q4
$248K Sell
3,185
-200
-6% -$17.7K 0.02% 138
2021
Q3
$323K Hold
3,385
0.03% 109
2021
Q2
$421K Hold
3,385
0.04% 105
2021
Q1
$446K Buy
3,385
+300
+10% +$41.1K 0.04% 101
2020
Q4
$409K Hold
3,085
0.04% 101
2020
Q3
$315K Hold
3,085
0.04% 99
2020
Q2
$268K Buy
+3,085
New +$246K 0.03% 102
2020
Q1
Sell
-3,085
Closed -$285K 108
2019
Q4
$285K Buy
+3,085
New +$271K 0.03% 98
2019
Q1
Sell
-3,900
Closed -$246K 108
2018
Q4
$246K Buy
3,900
+179
+5% +$12.3K 0.04% 97
2018
Q3
$294K Hold
3,721
0.04% 99
2018
Q2
$222K Buy
+3,721
New +$200K 0.03% 102

Other funds holding EXAS

Schaper Benz & Wise Investment Counsel's EXAS Position: Q1 2026 in Review

Schaper Benz & Wise Investment Counsel sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,000 shares — an estimated $305K sold.

Schaper Benz & Wise Investment Counsel first reported a position in EXAS in Q2 2018 and held it in 14 quarters. The position peaked at $446K in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Schaper Benz & Wise Investment Counsel reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Schaper Benz & Wise Investment Counsel sold 3,000 Exact Sciences shares in Q1 2026, an estimated $305K.
  • Schaper Benz & Wise Investment Counsel first reported a position in Exact Sciences in Q2 2018 and held it in 14 quarters.
  • Schaper Benz & Wise Investment Counsel's Exact Sciences position peaked at $446K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q1 2026, filed 28 Apr 2026.